サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：アレルギー用注射剤市場の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、免疫療法別、適応症別、アレルゲン別、流通チャネル別、地域別
市場調査レポート
商品コード
1398829

アレルギー用注射剤市場の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、免疫療法別、適応症別、アレルゲン別、流通チャネル別、地域別

Allergy Shots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日
ページ情報
英文 309 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
アレルギー用注射剤市場の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品別、免疫療法別、適応症別、アレルゲン別、流通チャネル別、地域別
出版日: 2023年12月18日
発行: Fairfield Market Research
ページ情報: 英文 309 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のアレルギー用注射剤の市場規模は大幅な成長を遂げ、2024年の約26億米ドルから2031年末には62億米ドルに成長する見込みです。

世界のアレルギー用注射剤市場は力強い成長を遂げていますが、その主な要因は、世界的に様々なアレルギーの発生率が上昇していることです。アレルギー性鼻炎（AR）、非アレルギー性鼻炎（NAR）、非特異的鼻炎の有病率の中央値はそれぞれ29.4％、18.1％、12.0％で、地域によってばらつきがあります。このような鼻炎の頻度の増加は、都市化した文化の導入、公害、食生活の乱れ、アルコールの使用などと相まって、食物アレルギーや皮膚アレルギーを含むアレルギー反応の急増につながっています。ライフスタイルの進化に伴い、アレルギー注射治療への需要が高まり、市場拡大の原動力となっています。

さらに、特殊な治療薬や組み換え免疫療法の進歩により、市場は絶えず進化しています。メーカー各社は、製品ポートフォリオの拡充、顧客基盤の拡大、地理的範囲の拡大を図るため、合併、買収、提携、パートナーシップを積極的に進めています。

同市場はその有望な成長にもかかわらず、課題に直面しています。アレルギー用注射剤の治療期間は長く、アレルギーの性質やステージにもよりますが、最長で3～5年に及びます。患者は年齢、健康状態、場所、経済的な制約のために治療を途中で中断することが多く、市場拡大の妨げとなっています。

さらに、アレルギー用注射剤や錠剤に伴う副作用も市場縮小の一因となっています。患者の10％以上が副作用を経験しており、その大半は口腔そう痒症や喉の不快感といった軽度から重度の局所反応です。

当レポートでは、世界のアレルギー用注射剤市場について調査し、市場の概要とともに、製品別、免疫療法別、適応症別、アレルゲン別、流通チャネル別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 生産高と貿易統計、2018年～2023年

第4章 価格分析、2018年～2023年

第5章 世界のアレルギー用注射剤市場の見通し、2018年～2031年

  • 世界のアレルギー用注射剤市場の見通し、製品別、金額（100万米ドル）、数量（個）別、2018年～2031年
  • 世界のアレルギー用注射剤市場の見通し、免疫療法別、金額（100万米ドル）、数量（個）、2018年～2031年
  • 世界のアレルギー用注射剤市場の見通し、適応症別、金額（100万米ドル）、数量（個）、2018年～2031年
  • 世界のアレルギー用注射剤市場の見通し、アレルゲン別、金額（100万米ドル）、数量（個）、2018年～2031年
  • 世界のアレルギー用注射剤市場の見通し、流通チャネル別、金額（100万米ドル）、数量（個）、2018年～2031年
  • 世界のアレルギー用注射剤市場の見通し、地域別、金額（100万米ドル）、数量（個）、2018年～2031年

第6章 北米のアレルギー用注射剤市場の見通し、2018年～2031年

第7章 欧州のアレルギー用注射剤市場の見通し、2018年～2031年

第8章 アジア太平洋のアレルギー用注射剤市場の見通し、2018年～2031年

第9章 ラテンアメリカのアレルギー用注射剤市場の見通し、2018年～2031年

第10章 中東・アフリカのアレルギー用注射剤市場の見通し、2018年～2031年

第11章 競合情勢

  • タイプ別対免疫療法別のヒートマップ
  • メーカーと免疫療法別のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競争力ダッシュボード
  • 企業プロファイル
    • Stallergenes Greer
    • Allergy Therapeutics
    • Aimmune Therapeutics
    • Anergis
    • Arrayit Corporation
    • Biomay AG
    • HAL Allergy Group
    • DBV Technologies

第12章 付録

目次

The global Allergy Shots Market is poised for substantial growth, propelling the market valuation from approximately US$ 2.6 billion in 2024 to an estimated US$ 6.2 billion by the end of 2031.

Driving Factors

The global Allergy Shots Market is experiencing robust growth, primarily attributed to the escalating incidence of various allergy types worldwide. Allergic rhinitis (AR), non-allergic rhinitis (NAR), and nonspecific rhinitis have shown median prevalence rates of 29.4%, 18.1%, and 12.0%, respectively, with variations by region. This increasing frequency of rhinitis, combined with the adoption of urbanized cultures, pollution, poor dietary habits, and alcohol use, has led to a surge in allergic reactions, including food and skin allergies. As lifestyles evolve, the demand for allergy shots treatments is rising, driving market expansion.

Moreover, the market continually evolves with advancements in specialized therapeutics and recombinant immunotherapies. Manufacturers are embracing mergers, acquisitions, collaborations, and partnerships to broaden their product portfolios, extend their client base, and expand their geographic reach.

Challenges and Barriers

Despite its promising growth, the Allergy Shots Market faces challenges. The treatment course for Allergy Shots is lengthy, lasting up to 3 to 5 years depending on the allergy's nature and stage. Patients often discontinue treatment midway due to age, health, location, or financial constraints, hindering market expansion.

Additionally, adverse side effects associated with allergy injections and tablets have contributed to a market decline. More than 10% of patients reported experiencing adverse reactions, with the majority being mild to severe local reactions such as oral pruritus or throat discomfort.

Country-wise Insights

  • United States: The U.S. market is booming due to increased investments by regional key players in advanced product development, offering user-friendly solutions with rapid results. For example, Moonlight Therapeutics received $1.9 million in funding for preclinical investigations and product development for peanut allergy treatment.
  • Germany: Germany is emerging as a lucrative market with a focus on increasing product launches. In September 2019, the introduction of ITULAZAX, an efficient sublingual Allergy Shots tablet for tree pollen allergy, marked a significant development.
  • Japan: Japan is becoming a prominent market driven by the increasing prevalence of allergic rhinitis, affecting 10-30% of individuals globally. The high sensitivity of pollen from trees and grass in the region necessitates effective allergy treatments.

Competitive Landscape

The Allergy Shots Market is marked by a consolidated landscape with a small number of significant market players. Leading companies such as Aimmune Therapeutics, Hollister Allergy, Leti Pharma, and Merck KGaA are driving market growth through strategies like mergers and acquisitions, expansion, new product development, and alliances.

Key Companies Covered

  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Anergis
  • Arrayit Corporation
  • Biomay AG
  • HAL Allergy Group
  • DBV Technologies
  • ALK Abello

Key Segments Covered in Allergy Shots Industry Research

Product:

  • SLIT Tablets
    • Odactra
    • Grastek
    • Ragwitek
    • Oralair
    • Actair
    • Others
  • Oral
    • Palforzia
  • Others
    • Injections
    • Others

Immunotherapy:

  • Sublingual Immunotherapy (SLIT)
  • Subcutaneous Immunotherapy (SCIT)
    • Specific Immunotherapy
  • Others

Indication:

  • Allergic Rhinitis
  • Allergic Asthma
  • Food Allergy
  • Atopic Dermatitis
  • Others

Allergen:

  • Pollens
    • Grass Pollens
    • Weed Pollens
    • Tree Pollens
      • House Dust Mites (HDM)
      • Mold
      • Animal Dander
      • Bee Venom
      • Cockroaches/Insects
      • Others

Distribution Channel:

  • Institutional Sales
    • Government Hospitals
    • Semi-Government Hospitals
    • Private Hospitals
  • Retail Sales
    • Retail Pharmacy
    • Drug Stores
    • Online Pharmacy

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Allergy Shots Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Allergy Shots Market Production Output, by Region, Value (US$ Bn) and Volume ('000 Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Allergy Shots Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Allergy Shots Market Outlook, 2018 - 2031

  • 5.1. Global Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. SLIT Tablets
        • 5.1.1.1.1. Odactra
        • 5.1.1.1.2. Grastek
        • 5.1.1.1.3. Ragwitek
        • 5.1.1.1.4. Oralair
        • 5.1.1.1.5. Actair
        • 5.1.1.1.6. Others
      • 5.1.1.2. Oral
        • 5.1.1.2.1. Palforzia
        • 5.1.1.2.2. Others
      • 5.1.1.3. Injections
      • 5.1.1.4. Others
  • 5.2. Global Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Sublingual Immunotherapy (SLIT)
      • 5.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 5.2.1.2.1. Specific Immunotherapy
      • 5.2.1.3. Others
  • 5.3. Global Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Allergic Rhinitis
      • 5.3.1.2. Allergic Asthma
      • 5.3.1.3. Food Allergy
      • 5.3.1.4. Atopic Dermatitis
      • 5.3.1.5. Others
  • 5.4. Global Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Pollens
        • 5.4.1.1.1. Grass Pollens
        • 5.4.1.1.2. Weed Pollens
        • 5.4.1.1.3. Tree Pollens
      • 5.4.1.2. House Dust Mites (HDM)
      • 5.4.1.3. Mold
      • 5.4.1.4. Animal Dander
      • 5.4.1.5. Bee Venom
      • 5.4.1.6. Cockroaches/Insects
      • 5.4.1.7. Others
  • 5.5. Others Global Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Institutional Sales
        • 5.5.1.1.1. Government Hospitals
        • 5.5.1.1.2. Semi-Government Hospitals
        • 5.5.1.1.3. Private Hospitals
      • 5.5.1.2. Retail Sales
        • 5.5.1.2.1. Retail Pharmacy
        • 5.5.1.2.2. Drug Stores
        • 5.5.1.2.3. Online Pharmacy
  • 5.6. Global Allergy Shots Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 5.6.1. Key Highlights
      • 5.6.1.1. North America
      • 5.6.1.2. Europe
      • 5.6.1.3. Asia Pacific
      • 5.6.1.4. Latin America
      • 5.6.1.5. Middle East & Africa

6. North America Allergy Shots Market Outlook, 2018 - 2031

  • 6.1. North America Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. SLIT Tablets
        • 6.1.1.1.1. Odactra
        • 6.1.1.1.2. Grastek
        • 6.1.1.1.3. Ragwitek
        • 6.1.1.1.4. Oralair
        • 6.1.1.1.5. Actair
        • 6.1.1.1.6. Others
      • 6.1.1.2. Oral
        • 6.1.1.2.1. Palforzia
        • 6.1.1.2.2. Others
      • 6.1.1.3. Injections
      • 6.1.1.4. Others
  • 6.2. North America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Sublingual Immunotherapy (SLIT)
      • 6.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 6.2.1.2.1. Specific Immunotherapy
      • 6.2.1.3. Others
  • 6.3. North America Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Allergic Rhinitis
      • 6.3.1.2. Allergic Asthma
      • 6.3.1.3. Food Allergy
      • 6.3.1.4. Atopic Dermatitis
      • 6.3.1.5. Others
  • 6.4. North America Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Pollens
        • 6.4.1.1.1. Grass Pollens
        • 6.4.1.1.2. Weed Pollens
        • 6.4.1.1.3. Tree Pollens
      • 6.4.1.2. House Dust Mites (HDM)
      • 6.4.1.3. Mold
      • 6.4.1.4. Animal Dander
      • 6.4.1.5. Bee Venom
      • 6.4.1.6. Cockroaches/Insects
      • 6.4.1.7. Others
  • 6.5. North America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. Institutional Sales
        • 6.5.1.1.1. Government Hospitals
        • 6.5.1.1.2. Semi-Government Hospitals
        • 6.5.1.1.3. Private Hospitals
      • 6.5.1.2. Retail Sales
        • 6.5.1.2.1. Retail Pharmacy
        • 6.5.1.2.2. Drug Stores
        • 6.5.1.2.3. Online Pharmacy
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis
  • 6.6. North America Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1. Key Highlights
      • 6.6.1.1. U.S. Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.2. U.S. Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.3. U.S. Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.4. U.S. Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.5. U.S. Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.6. Canada Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.7. Canada Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.8. Canada Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.9. Canada Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 6.6.1.10. Canada Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Allergy Shots Market Outlook, 2018 - 2031

  • 7.1. Europe Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. SLIT Tablets
        • 7.1.1.1.1. Odactra
        • 7.1.1.1.2. Grastek
        • 7.1.1.1.3. Ragwitek
        • 7.1.1.1.4. Oralair
        • 7.1.1.1.5. Actair
        • 7.1.1.1.6. Others
      • 7.1.1.2. Oral
        • 7.1.1.2.1. Palforzia
        • 7.1.1.2.2. Others
      • 7.1.1.3. Injections
      • 7.1.1.4. Others
  • 7.2. Europe Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Sublingual Immunotherapy (SLIT)
      • 7.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 7.2.1.2.1. Specific Immunotherapy
      • 7.2.1.3. Others
  • 7.3. Europe Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Allergic Rhinitis
      • 7.3.1.2. Allergic Asthma
      • 7.3.1.3. Food Allergy
      • 7.3.1.4. Atopic Dermatitis
      • 7.3.1.5. Others
  • 7.4. Europe Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Pollens
        • 7.4.1.1.1. Grass Pollens
        • 7.4.1.1.2. Weed Pollens
        • 7.4.1.1.3. Tree Pollens
      • 7.4.1.2. House Dust Mites (HDM)
      • 7.4.1.3. Mold
      • 7.4.1.4. Animal Dander
      • 7.4.1.5. Bee Venom
      • 7.4.1.6. Cockroaches/Insects
      • 7.4.1.7. Others
  • 7.5. Europe Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Institutional Sales
        • 7.5.1.1.1. Government Hospitals
        • 7.5.1.1.2. Semi-Government Hospitals
        • 7.5.1.1.3. Private Hospitals
      • 7.5.1.2. Retail Sales
        • 7.5.1.2.1. Retail Pharmacy
        • 7.5.1.2.2. Drug Stores
        • 7.5.1.2.3. Online Pharmacy
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis
  • 7.6. Europe Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1. Key Highlights
      • 7.6.1.1. Germany Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.2. Germany Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.3. Germany Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.4. Germany Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.5. Germany Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.6. U.K. Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.7. U.K. Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.8. U.K. Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.9. U.K. Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.10. U.K. Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.11. France Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.12. France Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.13. France Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.14. France Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.15. France Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.16. Italy Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.17. Italy Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.18. Italy Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.19. Italy Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.20. Italy Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.21. Turkey Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.22. Turkey Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.23. Turkey Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.24. Turkey Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.25. Turkey Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.26. Russia Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.27. Russia Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.28. Russia Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.29. Russia Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.30. Russia Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.31. Rest of Europe Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.32. Rest of Europe Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.33. Rest of Europe Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.34. Rest of Europe Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 7.6.1.35. Rest of Europe Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Allergy Shots Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. SLIT Tablets
        • 8.1.1.1.1. Odactra
        • 8.1.1.1.2. Grastek
        • 8.1.1.1.3. Ragwitek
        • 8.1.1.1.4. Oralair
        • 8.1.1.1.5. Actair
        • 8.1.1.1.6. Others
      • 8.1.1.2. Oral
        • 8.1.1.2.1. Palforzia
        • 8.1.1.2.2. Others
      • 8.1.1.3. Injections
      • 8.1.1.4. Others
  • 8.2. Asia Pacific Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Sublingual Immunotherapy (SLIT)
      • 8.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 8.2.1.2.1. Specific Immunotherapy
      • 8.2.1.3. Others
  • 8.3. Asia Pacific Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Allergic Rhinitis
      • 8.3.1.2. Allergic Asthma
      • 8.3.1.3. Food Allergy
      • 8.3.1.4. Atopic Dermatitis
      • 8.3.1.5. Others
  • 8.4. Asia Pacific Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Pollens
        • 8.4.1.1.1. Grass Pollens
        • 8.4.1.1.2. Weed Pollens
        • 8.4.1.1.3. Tree Pollens
      • 8.4.1.2. House Dust Mites (HDM)
      • 8.4.1.3. Mold
      • 8.4.1.4. Animal Dander
      • 8.4.1.5. Bee Venom
      • 8.4.1.6. Cockroaches/Insects
      • 8.4.1.7. Others
  • 8.5. Asia Pacific Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. Institutional Sales
        • 8.5.1.1.1. Government Hospitals
        • 8.5.1.1.2. Semi-Government Hospitals
        • 8.5.1.1.3. Private Hospitals
      • 8.5.1.2. Retail Sales
        • 8.5.1.2.1. Retail Pharmacy
        • 8.5.1.2.2. Drug Stores
        • 8.5.1.2.3. Online Pharmacy
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis
  • 8.6. Asia Pacific Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1. Key Highlights
      • 8.6.1.1. China Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.2. China Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.3. China Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.4. China Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.5. China Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.6. Japan Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.7. Japan Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.8. Japan Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.9. Japan Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.10. Japan Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.11. South Korea Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.12. South Korea Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.13. South Korea Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.14. South Korea Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.15. South Korea Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.16. India Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.17. India Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.18. India Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.19. India Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.20. India Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.21. Southeast Asia Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.22. Southeast Asia Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.23. Southeast Asia Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.24. Southeast Asia Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.25. Southeast Asia Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.26. Rest of Asia Pacific Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.27. Rest of Asia Pacific Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.28. Rest of Asia Pacific Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.29. Rest of Asia Pacific Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 8.6.1.30. Rest of Asia Pacific Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Allergy Shots Market Outlook, 2018 - 2031

  • 9.1. Latin America Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. SLIT Tablets
        • 9.1.1.1.1. Odactra
        • 9.1.1.1.2. Grastek
        • 9.1.1.1.3. Ragwitek
        • 9.1.1.1.4. Oralair
        • 9.1.1.1.5. Actair
        • 9.1.1.1.6. Others
      • 9.1.1.2. Oral
        • 9.1.1.2.1. Palforzia
        • 9.1.1.2.2. Others
      • 9.1.1.3. Injections
      • 9.1.1.4. Others
  • 9.2. Latin America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.2.1.1. Sublingual Immunotherapy (SLIT)
      • 9.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 9.2.1.2.1. Specific Immunotherapy
      • 9.2.1.3. Others
  • 9.3. Latin America Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Allergic Rhinitis
      • 9.3.1.2. Allergic Asthma
      • 9.3.1.3. Food Allergy
      • 9.3.1.4. Atopic Dermatitis
      • 9.3.1.5. Others
  • 9.4. Latin America Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Pollens
        • 9.4.1.1.1. Grass Pollens
        • 9.4.1.1.2. Weed Pollens
        • 9.4.1.1.3. Tree Pollens
      • 9.4.1.2. House Dust Mites (HDM)
      • 9.4.1.3. Mold
      • 9.4.1.4. Animal Dander
      • 9.4.1.5. Bee Venom
      • 9.4.1.6. Cockroaches/Insects
      • 9.4.1.7. Others
  • 9.5. Latin America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.5.1. Key Highlights
      • 9.5.1.1. Institutional Sales
        • 9.5.1.1.1. Government Hospitals
        • 9.5.1.1.2. Semi-Government Hospitals
        • 9.5.1.1.3. Private Hospitals
      • 9.5.1.2. Retail Sales
        • 9.5.1.2.1. Retail Pharmacy
        • 9.5.1.2.2. Drug Stores
        • 9.5.1.2.3. Online Pharmacy
    • 9.5.2. BPS Analysis/Market Attractiveness Analysis
  • 9.6. Latin America Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1. Key Highlights
      • 9.6.1.1. Brazil Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.2. Brazil Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.3. Brazil Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.4. Brazil Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.5. Brazil Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.6. Mexico Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.7. Mexico Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.8. Mexico Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.9. Mexico Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.10. Mexico Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.11. Argentina Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.12. Argentina Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.13. Argentina Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.14. Argentina Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.15. Argentina Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.16. Rest of Latin America Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.17. Rest of Latin America Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.18. Rest of Latin America Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.19. Rest of Latin America Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 9.6.1.20. Rest of Latin America Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Allergy Shots Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. SLIT Tablets
        • 10.1.1.1.1. Odactra
        • 10.1.1.1.2. Grastek
        • 10.1.1.1.3. Ragwitek
        • 10.1.1.1.4. Oralair
        • 10.1.1.1.5. Actair
        • 10.1.1.1.6. Others
      • 10.1.1.2. Oral
        • 10.1.1.2.1. Palforzia
        • 10.1.1.2.2. Others
      • 10.1.1.3. Injections
      • 10.1.1.4. Others
  • 10.2. Middle East & Africa Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Sublingual Immunotherapy (SLIT)
      • 10.2.1.2. Subcutaneous Immunotherapy (SCIT)
        • 10.2.1.2.1. Specific Immunotherapy
      • 10.2.1.3. Others
  • 10.3. Middle East & Africa Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Allergic Rhinitis
      • 10.3.1.2. Allergic Asthma
      • 10.3.1.3. Food Allergy
      • 10.3.1.4. Atopic Dermatitis
      • 10.3.1.5. Others
  • 10.4. Middle East & Africa Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. Cell Wall Synthesis Inhibitors
      • 10.4.1.2. Protein Synthesis Inhibitors
      • 10.4.1.3. DNA Synthesis Inhibitors
      • 10.4.1.4. RNA Synthesis Inhibitors
      • 10.4.1.5. Others
  • 10.5. Middle East & Africa Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.5.1. Key Highlights
      • 10.5.1.1. Institutional Sales
        • 10.5.1.1.1. Government Hospitals
        • 10.5.1.1.2. Semi-Government Hospitals
        • 10.5.1.1.3. Private Hospitals
      • 10.5.1.2. Retail Sales
        • 10.5.1.2.1. Retail Pharmacy
        • 10.5.1.2.2. Drug Stores
        • 10.5.1.2.3. Online Pharmacy
    • 10.5.2. BPS Analysis/Market Attractiveness Analysis
  • 10.6. Middle East & Africa Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1. Key Highlights
      • 10.6.1.1. GCC Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.2. GCC Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.3. GCC Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.4. GCC Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.5. GCC Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.6. South Africa Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.7. South Africa Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.8. South Africa Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.9. South Africa Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.10. South Africa Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.11. Egypt Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.12. Egypt Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.13. Egypt Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.14. Egypt Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.15. Egypt Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.16. Nigeria Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.17. Nigeria Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.18. Nigeria Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.19. Nigeria Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.20. Nigeria Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.21. Rest of Middle East & Africa Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.22. Rest of Middle East & Africa Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.23. Rest of Middle East & Africa Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.24. Rest of Middle East & Africa Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
      • 10.6.1.25. Rest of Middle East & Africa Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By Species vs by Immunotherapy Heat map
  • 11.2. Manufacturer vs by Immunotherapy Heat map
  • 11.3. Company Market Share Analysis, 2023
  • 11.4. Competitive Dashboard
  • 11.5. Company Profiles
    • 11.5.1. Stallergenes Greer
      • 11.5.1.1. Company Overview
      • 11.5.1.2. Product Portfolio
      • 11.5.1.3. Financial Overview
      • 11.5.1.4. Business Strategies and Development
    • 11.5.2. Allergy Therapeutics
      • 11.5.2.1. Company Overview
      • 11.5.2.2. Product Portfolio
      • 11.5.2.3. Financial Overview
      • 11.5.2.4. Business Strategies and Development
    • 11.5.3. Aimmune Therapeutics
      • 11.5.3.1. Company Overview
      • 11.5.3.2. Product Portfolio
      • 11.5.3.3. Financial Overview
      • 11.5.3.4. Business Strategies and Development
    • 11.5.4. Anergis
      • 11.5.4.1. Company Overview
      • 11.5.4.2. Product Portfolio
      • 11.5.4.3. Financial Overview
      • 11.5.4.4. Business Strategies and Development
    • 11.5.5. Arrayit Corporation
      • 11.5.5.1. Company Overview
      • 11.5.5.2. Product Portfolio
      • 11.5.5.3. Financial Overview
      • 11.5.5.4. Business Strategies and Development
    • 11.5.6. Biomay AG
      • 11.5.6.1. Company Overview
      • 11.5.6.2. Product Portfolio
      • 11.5.6.3. Financial Overview
      • 11.5.6.4. Business Strategies and Development
    • 11.5.7. HAL Allergy Group
      • 11.5.7.1. Company Overview
      • 11.5.7.2. Product Portfolio
      • 11.5.7.3. Financial Overview
      • 11.5.7.4. Business Strategies and Development
    • 11.5.8. DBV Technologies
      • 11.5.8.1. Company Overview
      • 11.5.8.2. Product Portfolio
      • 11.5.8.3. Financial Overview
      • 11.5.8.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations